论文部分内容阅读
据Vegas AJ 2016年1月25日(Nat Biotechnol,2016 Jan 25.doi:10.1038/nbt.3162.)报道,美国MIT波士顿儿童医院及其他研究单位的研究人员设计了一种新型材料能够在进行胰岛细胞移植之前将细胞包裹起来。该研究在小鼠模型上进行了实验检测,结果表明这些胶囊化的人类胰岛细胞能够治疗糖尿病,并且效果长达6个月,同时不会引起机体产生免疫应答。对于患有1型糖尿病的病人来说,他们的免疫系统会攻击胰腺,最终导致病人失去血糖调节能力。这些病人必须不断监测血
According to Vegas AJ, January 25, 2016 (Nat Biotechnol, 2016 Jan 25.doi: 10.1038 / nbt.3162.) Researchers at Boston Children’s Hospital and other research facilities at MIT in the United States have devised a new type of material that can be used in islets Wrap cells before cell transplantation. The study, which was conducted in a mouse model, showed that these encapsulated human islet cells can treat diabetes and last up to six months without causing the body to develop an immune response. For people with type 1 diabetes, their immune system attacks the pancreas, eventually causing the patient to lose its ability to regulate blood sugar. These patients must constantly monitor blood